Baseline | Follow-up | ||||||||||||||
Patient no | Age (y) | Diagnoses | EP | PR | Ki67 (%) | HIF-1α score | SUVFDGpeak | TBR2 h | TBR4 h | Ki67 (%) | HIF-1α score | SUVFDG peak | TBR2 h | TBR4 h | Outcome |
1 | 61 | Right primary | +++ | +++ | 10 | 5 | 7.33 | 0.89 | 0.81 | 5 | 0 | 2.00 | 0.82 | 0.77 | Stable disease |
M | 4.30 | 0.73 | 0.63 | 0.90 | 0.27 | 0.43 | PR | ||||||||
2 | 55 | Left M | ++ | − | 24 | 8.02 | 1.13 | 1.20 | 7.10 | 1.58 | 1.83 | PD | |||
M | ++ | − | 10 | 9.65 | 0.92 | 1.09 | 4.10 | 1.18 | 1.12 | Stable disease | |||||
3 | 74 | Left primary | ++ | ++ | 10 | 5 | 2.74 | 1.27 | 1.31 | 15 | 5 | 2.84 | 1.34 | 1.41 | PD |
4 | 65 | Right primary | +++ | ++ | 20 | 8.26 | 1.03 | 1.05 | 5 | 1 | 8.26 | 0.98 | 0.84 | PR | |
5 | 56 | Left M | ++ | + | 30 | 4 | 6.10 | 1.62 | 1.31 | 6.70 | 0.88 | 1.11 | PD | ||
6 | 56 | Left primary | +++ | +++ | 40 | 4 | 7.61 | 1.25 | 1.50 | 5 | 4 | 4.60 | 0.80 | 0.91 | Stable disease |
M | 6.70 | 0.62 | 0.66 | 3.30 | 0.29 | 0.21 | PR | ||||||||
7 | 74 | Left primary | ++ | ++ | 20 | 5 | 3.20 | 0.81 | 0.89 | 1 | 5 | 3.20 | 0.73 | 0.88 | PR |
8 | 58 | M | +++ | +++ | 15 | 7.10 | 1.66 | 2.29 | 13.04 | 1.83 | 2.15 | PD | |||
9 | 74 | Right primary | +++ | +++ | 75 | 1.40 | 0.80 | 1.10 | 5 | 3.40 | 0.50 | 0.90 | Stable disease | ||
10 | 70 | Right primary | +++ | +++ | 50 | 2.90 | 1.18 | 1.18 | 5 | 1.60 | 0.90 | 1.15 | PR | ||
M1 | 4.50 | 1.03 | 1.06 | 12.80 | 1.14 | 1.14 | PR | ||||||||
M2 | 3.83 | 0.90 | 0.94 | 1.58 | 0.88 | 1.01 | PR | ||||||||
11 | 64 | M1 | ++ | ++ | 50 | 8.00 | 1.38 | 1.87 | 11.50 | 1.77 | 2.05 | PD | |||
M2 | 12.20 | 1.18 | 1.27 | 11.10 | 1.97 | 2.28 | PD | ||||||||
M3 | 10.90 | 1.14 | 1.27 | 6.50 | 1.63 | 1.55 | PD | ||||||||
M4 | 13.49 | 1.02 | 1.34 | 10.10 | 1.17 | 1.03 | PD | ||||||||
M5 | 8.74 | 1.19 | 1.14 | 7.90 | 1.31 | 1.16 | PD | ||||||||
12 | 55 | Right primary | +++ | +++ | 30 | 5.45 | 1.23 | 1.30 | PD | ||||||
M1 | 4.50 | 1.98 | 1.65 | PD | |||||||||||
M2 | 4.00 | 1.39 | 0.93 | PD | |||||||||||
M3 | 5.80 | 1.55 | 2.26 | PD | |||||||||||
M4 | 6.67 | 3.07 | 1.89 | PD | |||||||||||
M5 | 6.18 | 1.29 | 1.79 | PD | |||||||||||
M6 | 5.17 | 1.60 | 1.63 | PD | |||||||||||
M7 | 5.81 | 1.93 | 1.57 | PD | |||||||||||
13 | 58 | Left primary | +++ | +++ | 20 | 4.50 | 0.76 | 0.80 | PR | ||||||
M | 4.40 | 0.72 | 0.67 | PR | |||||||||||
14 | 82 | Left primary | +++ | +++ | 3.93 | 1.06 | 1.02 | PR | |||||||
15 | 67 | Left primary | +++ | +++ | 5 | 4 | 6.60 | 0.83 | 0.88 | PR | |||||
16 | 59 | Left primary | +++ | +++ | 4 | 2.46 | 0.72 | 0.95 | Stable disease | ||||||
17 | 78 | Left primary | +++ | +++ | 15 | 5 | 4.50 | 0.86 | 0.76 | PR | |||||
18 | 60 | M1 | +++ | +++ | 5.60 | 0.99 | 0.91 | Stable disease | |||||||
M2 | 4.30 | 0.88 | 0.80 | Stable disease | |||||||||||
M3 | 6.80 | 1.01 | 0.93 | Stable disease | |||||||||||
M4 | 8.20 | 1.12 | 1.28 | Stable disease | |||||||||||
M5 | 7.62 | 1.10 | 1.06 | Stable disease | |||||||||||
19 | 77 | M1 | +++ | ++ | 85 | 9.58 | 1.04 | 1.98 | PD | ||||||
M2 | 6.74 | 0.94 | 0.98 | PD | |||||||||||
M3 | 5 | 8.20 | 1.14 | 1.40 | PD | ||||||||||
20 | 59 | M1 | 12.90 | 1.08 | 1.11 | PD | |||||||||
M2 | +++ | ++ | 13.35 | 1.03 | 1.31 | PD | |||||||||
M3 | 8.40 | 1.86 | 1.61 | PD |
+++ = strong positive; ++ = intermediate positive; − = negative; + = weak positive; M = metastasis.